BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29463208)

  • 1. The VAAST Variant Prioritizer (VVP): ultrafast, easy to use whole genome variant prioritization tool.
    Flygare S; Hernandez EJ; Phan L; Moore B; Li M; Fejes A; Hu H; Eilbeck K; Huff C; Jorde L; G Reese M; Yandell M
    BMC Bioinformatics; 2018 Feb; 19(1):57. PubMed ID: 29463208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrafast and scalable variant annotation and prioritization with big functional genomics data.
    Huang D; Yi X; Zhou Y; Yao H; Xu H; Wang J; Zhang S; Nong W; Wang P; Shi L; Xuan C; Li M; Wang J; Li W; Kwan HS; Sham PC; Wang K; Li MJ
    Genome Res; 2020 Dec; 30(12):1789-1801. PubMed ID: 33060171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PERCH: A Unified Framework for Disease Gene Prioritization.
    Feng BJ
    Hum Mutat; 2017 Mar; 38(3):243-251. PubMed ID: 27995669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JWES: a new pipeline for whole genome/exome sequence data processing, management, and gene-variant discovery, annotation, prediction, and genotyping.
    Ahmed Z; Renart EG; Mishra D; Zeeshan S
    FEBS Open Bio; 2021 Sep; 11(9):2441-2452. PubMed ID: 34370400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinical Genome and Ancestry Report: An interactive web application for prioritizing clinically implicated variants from genome sequencing data with ancestry composition.
    Lee IH; Negron JA; Hernandez-Ferrer C; Alvarez WJ; Mandl KD; Kong SW
    Hum Mutat; 2020 Feb; 41(2):387-396. PubMed ID: 31691385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A machine learning approach based on ACMG/AMP guidelines for genomic variant classification and prioritization.
    Nicora G; Zucca S; Limongelli I; Bellazzi R; Magni P
    Sci Rep; 2022 Feb; 12(1):2517. PubMed ID: 35169226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ClinGen Pathogenicity Calculator: a configurable system for assessing pathogenicity of genetic variants.
    Patel RY; Shah N; Jackson AR; Ghosh R; Pawliczek P; Paithankar S; Baker A; Riehle K; Chen H; Milosavljevic S; Bizon C; Rynearson S; Nelson T; Jarvik GP; Rehm HL; Harrison SM; Azzariti D; Powell B; Babb L; Plon SE; Milosavljevic A;
    Genome Med; 2017 Jan; 9(1):3. PubMed ID: 28081714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome analysis and knowledge-driven variant interpretation with TGex.
    Dahary D; Golan Y; Mazor Y; Zelig O; Barshir R; Twik M; Iny Stein T; Rosner G; Kariv R; Chen F; Zhang Q; Shen Y; Safran M; Lancet D; Fishilevich S
    BMC Med Genomics; 2019 Dec; 12(1):200. PubMed ID: 31888639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic Scan Procedure for Detecting Rare-Variant Association Regions in Whole-Genome Sequencing Studies.
    Li Z; Li X; Liu Y; Shen J; Chen H; Zhou H; Morrison AC; Boerwinkle E; Lin X
    Am J Hum Genet; 2019 May; 104(5):802-814. PubMed ID: 30982610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene-level specification of the ACMG/AMP guidelines for sequence variant interpretation.
    Rivera-Muñoz EA; Milko LV; Harrison SM; Azzariti DR; Kurtz CL; Lee K; Mester JL; Weaver MA; Currey E; Craigen W; Eng C; Funke B; Hegde M; Hershberger RE; Mao R; Steiner RD; Vincent LM; Martin CL; Plon SE; Ramos E; Rehm HL; Watson M; Berg JS
    Hum Mutat; 2018 Nov; 39(11):1614-1622. PubMed ID: 30311389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CADD v1.7: using protein language models, regulatory CNNs and other nucleotide-level scores to improve genome-wide variant predictions.
    Schubach M; Maass T; Nazaretyan L; Röner S; Kircher M
    Nucleic Acids Res; 2024 Jan; 52(D1):D1143-D1154. PubMed ID: 38183205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying Mendelian disease genes with the variant effect scoring tool.
    Carter H; Douville C; Stenson PD; Cooper DN; Karchin R
    BMC Genomics; 2013; 14 Suppl 3(Suppl 3):S3. PubMed ID: 23819870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying the potential of functional evidence to reclassify variants of uncertain significance in the categorical and Bayesian interpretation frameworks.
    Brnich SE; Rivera-Muñoz EA; Berg JS
    Hum Mutat; 2018 Nov; 39(11):1531-1541. PubMed ID: 30095857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prioritizing disease-linked variants, genes, and pathways with an interactive whole-genome analysis pipeline.
    Lee IH; Lee K; Hsing M; Choe Y; Park JH; Kim SH; Bohn JM; Neu MB; Hwang KB; Green RC; Kohane IS; Kong SW
    Hum Mutat; 2014 May; 35(5):537-47. PubMed ID: 24478219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VarElect: the phenotype-based variation prioritizer of the GeneCards Suite.
    Stelzer G; Plaschkes I; Oz-Levi D; Alkelai A; Olender T; Zimmerman S; Twik M; Belinky F; Fishilevich S; Nudel R; Guan-Golan Y; Warshawsky D; Dahary D; Kohn A; Mazor Y; Kaplan S; Iny Stein T; Baris HN; Rappaport N; Safran M; Lancet D
    BMC Genomics; 2016 Jun; 17 Suppl 2(Suppl 2):444. PubMed ID: 27357693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-Genome Sequencing of 502 Individuals from Latvia: The First Step towards a Population-Specific Reference of Genetic Variation.
    Reščenko R; Brīvība M; Atava I; Rovīte V; Pečulis R; Silamiķelis I; Ansone L; Megnis K; Birzniece L; Leja M; Xu L; Shi X; Zhou Y; Slaitas A; Hou Y; Kloviņš J
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical interpretation and implications of whole-genome sequencing.
    Dewey FE; Grove ME; Pan C; Goldstein BA; Bernstein JA; Chaib H; Merker JD; Goldfeder RL; Enns GM; David SP; Pakdaman N; Ormond KE; Caleshu C; Kingham K; Klein TE; Whirl-Carrillo M; Sakamoto K; Wheeler MT; Butte AJ; Ford JM; Boxer L; Ioannidis JP; Yeung AC; Altman RB; Assimes TL; Snyder M; Ashley EA; Quertermous T
    JAMA; 2014 Mar; 311(10):1035-45. PubMed ID: 24618965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of genotyping-by-sequencing analysis methods on low-coverage crop datasets shows advantages of a new workflow, GB-eaSy.
    Wickland DP; Battu G; Hudson KA; Diers BW; Hudson ME
    BMC Bioinformatics; 2017 Dec; 18(1):586. PubMed ID: 29281959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GenePy - a score for estimating gene pathogenicity in individuals using next-generation sequencing data.
    Mossotto E; Ashton JJ; O'Gorman L; Pengelly RJ; Beattie RM; MacArthur BD; Ennis S
    BMC Bioinformatics; 2019 May; 20(1):254. PubMed ID: 31096927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning random forest for predicting oncosomatic variant NGS analysis.
    Pellegrino E; Jacques C; Beaufils N; Nanni I; Carlioz A; Metellus P; Ouafik L
    Sci Rep; 2021 Nov; 11(1):21820. PubMed ID: 34750410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.